993 results on '"Immunoelectrophoresis methods"'
Search Results
2. Physicochemical Properties of IgD-type M Protein by Electrophoretic Analysis.
- Author
-
Imoto M and Kamisako T
- Subjects
- Humans, Female, Male, Immunoelectrophoresis methods, Adult, Immunoglobulin D immunology, Immunoglobulin G
- Abstract
Background: We examined the physicochemical properties of IgD-type M protein from 10 patients with IgD-type M protein and those with other types of M protein., Methods: Identification of the L-chain type by routine methods (Immunoelectrophoresis: IEP, Immunofixation electrophoresis; IFE), detection of IgD-IgG complexes and the changes in the mobility by treatment with acid., Results: Identification of the L-chain type by both IEP and IFE was impossible. Only one patient revealed the possibility of IgD-IgG complex bands in 6 of the 10 samples. Changes in mobility by treatment with acid were observed in 8 of the 10 samples of IgD-type M protein., Conclusions: These abnormalities are caused by the primary structure of IgD, which may be related to the well-known weak reactivity with L-chain antibody.
- Published
- 2024
- Full Text
- View/download PDF
3. Serum monoclonal immunoglobulin light-chain detection differs between immunofixation electrophoresis methods in patients with AL amyloidosis.
- Author
-
Kawano Y, Nishimura N, and Yasunaga JI
- Subjects
- Humans, Female, Male, Aged, Middle Aged, Immunoelectrophoresis methods, Aged, 80 and over, Immunoglobulin Light Chains blood, Immunoglobulin Light-chain Amyloidosis diagnosis, Immunoglobulin Light-chain Amyloidosis blood
- Abstract
Serum immunofixation electrophoresis (IFE) is often performed for screening monoclonal proteins (M proteins) in immunoglobulin light-chain amyloidosis (AL amyloidosis). However, the performance of serum IFE for detecting M protein in AL amyloidosis patients is often insufficient. In this study, we examined the detection rate of serum M protein in newly diagnosed AL amyloidosis patients and analyzed differences in M protein detection between IFE methods. Among 60 patients newly diagnosed with AL amyloidosis, 22 had undetectable serum M protein by IFE with the Epalyzer2 system. Samples with undetectable M protein had significantly lower involved serum-free light-chain (iFLC) and a smaller difference between involved and uninvolved serum-free light-chain (dFLC) values than samples with IFE-detectable monoclonal light chains. When samples that tested negative for M protein by the Epalyzer2 system were retested by IFE with the HYDRASYS 2 system, 50% had IFE-detectable monoclonal light chains. The IFE system and reagents used may affect serum monoclonal immunoglobulin light-chain detection in AL amyloidosis patients, especially those with low iFLC or low dFLC samples. More attention should be paid to the performance of IFE systems, since it may affect the diagnostic and therapeutic evaluation of AL amyloidosis patients., (© 2024. Japanese Society of Hematology.)
- Published
- 2024
- Full Text
- View/download PDF
4. Impact of M-protein detection on the response evaluations of patients undergoing treatment with the IgG-κ monoclonal antibodies daratumumab or isatuximab, and discrepancies between immunofixation electrophoresis (IFE) systems and reagents.
- Author
-
Shirouchi Y, Kaihara K, Sekita T, Amano N, Nakayama K, Miyake K, Abe H, Oinuma H, and Maruyama D
- Subjects
- Humans, Female, Aged, Male, Middle Aged, Immunoelectrophoresis methods, Treatment Outcome, Immunoglobulin G blood, Immunoglobulin kappa-Chains blood, Indicators and Reagents, Antibodies, Monoclonal therapeutic use, Multiple Myeloma drug therapy, Multiple Myeloma blood, Antibodies, Monoclonal, Humanized therapeutic use, Myeloma Proteins analysis
- Abstract
Background: Immunofixation electrophoresis (IFE) is the standard method for confirming the presence of a monoclonal protein (M-protein) at multiple myeloma (MM) diagnosis. IFE is also essential at assessment of complete response (CR) and stringent CR during treatment. As the CR assessment is influenced by daratumumab and isatuximab, HYDRASHIFT assays were developed., Methods: Samples from patients under treatment that included daratumumab or isatuximab were tested and monitored by IFE on the HYDRASYS system using HYDRASHIFT assays (HYDRASYS/HYDRASHIFT) and by IFE on the Epalyzer2 system (Epalyzer)., Results: The IFE using HYDRASYS/HYDRASHIFT avoided a false positive caused by drug-related IgG-κ and contributed to accurate assessment of CR. Furthermore, HYDRASYS/HYDRASHIFT detected small M-proteins at early relapse and detected free light chains (FLCs) in patients with renal impairment exhibiting high serum FLCs despite being often missed on Epalyzer., Conclusion: Sensitivity and specificity of M-protein detection vary greatly depending on the IFE system and reagents used., (© 2024 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
5. Urine immunofixation electrophoresis and serum free light chain analyses benefit diagnosis of multiple myeloma in orthopedic patients with normal serum total proteins, creatinine, calcium, and hemoglobin.
- Author
-
Jia Z, Xia J, and Lu Q
- Subjects
- Humans, Female, Male, Middle Aged, Aged, Hemoglobins analysis, Creatinine blood, Immunoglobulin Light Chains blood, Immunoglobulin Light Chains urine, Immunoelectrophoresis methods, Aged, 80 and over, Adult, Blood Proteins analysis, Multiple Myeloma diagnosis, Multiple Myeloma blood, Calcium blood
- Abstract
Background: A substantial number of patients with multiple myeloma (MM) who have bone destruction are initially admitted into the orthopedic service at the hospital. However, routine laboratory testing usually fails to identify these patients, thus delaying optimal therapy. Therefore, there is a clear medical need for early diagnosis of MM in these patients., Methods: Between 2019 and 2021, 42 patients receiving treatment for orthopedic conditions had normal hemoglobin (Hb), total protein (TP), albumin (ALB), creatinine (CREA), and blood calcium (Ca) levels before their surgical procedure(s) but were subsequently pathologically confirmed to have MM, based on their presenting orthopedic symptoms. During the same period, 52 patients with orthopedic conditions were pathologically excluded from the diagnosis of MM and were recruited into our control group. Serum free light chain (sFLC) testing was performed in 94 consecutive patients in the orthopedic service using Siemens N Latex FLC kits. The levels of Hb, TP, ALB, CREA, and Ca were also measured. All 42 patients with MM were divided into group A (n = 25: κ proliferation) and group B (n = 17: λ proliferation) by the pathology department., Results: There were no significant differences in levels of Hb, TP, ALB, CREA, and Ca between group A and group B and the control group. However, the sFLC κ/λ ratio of group A and B was also significantly different from that of the control group (P < .001). The results of serum immunofixation electrophoresis (IFE) testing demonstrated negative results in 14 cases (58.3%) in group A and 4 cases (25.0%) in group B., Conclusions: Some patients with orthopedic conditions who do not have typical MM laboratory results, such as those with abnormal Hb, TP, ALB, CREA, and Ca levels before their operation(s), actually have MM. MM should be highly suspected in patients with unexplained bone lesions and with an abnormal sFLC κ/λ ratio. Further tissue or bone marrow biopsy is needed in these patients even if serum and urine IFE results are negative and light chain ratio is normal., (© The Author(s) 2023. Published by Oxford University Press on behalf of American Society for Clinical Pathology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
6. Isatuximab-Specific Immunofixation Electrophoresis Assay to Remove Interference in Serum M-Protein Measurement in Patients with Multiple Myeloma.
- Author
-
Thoren K, Menad S, Nouadje G, and Macé S
- Subjects
- Humans, Antibodies, Monoclonal therapeutic use, Multiple Myeloma blood, Multiple Myeloma drug therapy, Multiple Myeloma immunology, Multiple Myeloma diagnosis, Immunoelectrophoresis methods, Myeloma Proteins analysis, Antibodies, Monoclonal, Humanized therapeutic use
- Abstract
Background: Isatuximab, an IgG-kappa (IgGκ) anti-cluster of differentiation 38 (CD38) monoclonal antibody approved for use in patients with relapsed or refractory multiple myeloma (MM), can potentially interfere with the visualization of endogenous monoclonal protein (M-protein) on standard immunofixation electrophoresis (IFE) and lead to inaccurate classification of a patient's response to therapy. The Hydrashift 2/4 isatuximab IFE assay (Hydrashift isatuximab assay) removes isatuximab interference from IFE. Using samples from patients enrolled in clinical trials of isatuximab-based therapy for MM, we demonstrate how the Hydrashift isatuximab assay improves the ability to detect residual M-protein and offer recommendations for when the assay is most useful., Methods: Samples from 141 patients with a variety of known M-protein isotypes were selected and analyzed by standard IFE and the Hydrashift isatuximab assay. A positive control containing isatuximab was run on every standard IFE and Hydrashift gel., Results: The Hydrashift isatuximab assay reliably shifted the migration of isatuximab in patient samples. Standard IFE was adequate for determining 104 patients' M-protein status, and the Hydrashift isatuximab assay confirmed these results. In samples from 37 patients with a history of IgGκ MM and a single IgGκ band visible on standard IFE near the isatuximab migration site, the Hydrashift isatuximab assay was able to separate isatuximab from endogenous M-protein, identifying residual M-protein in 17 samples and preventing false-positive interpretations of standard IFE in 20 samples., Conclusions: The Hydrashift isatuximab assay is most useful in patients with known IgGκ MM when a single IgGκ band appears near the isatuximab migration site on standard IFE during isatuximab-based therapy., Clinicaltrials.gov Registration Numbers: NCT03275285 and NCT03319667., (© Association for Diagnostics & Laboratory Medicine 2024.)
- Published
- 2024
- Full Text
- View/download PDF
7. Isoelectric focusing followed by affinity immunoblotting to detect monoclonal free light chains in monoclonal gammopathies: Comparison with immunofixation electrophoresis and free light chain ratio.
- Author
-
Zeman D, Štork M, Švancarová L, Borský M, Pospíšilová M, Adam Z, Beňovská M, and Pour L
- Subjects
- Humans, Immunoblotting methods, Immunoelectrophoresis methods, Aged, Female, Male, Middle Aged, Multiple Myeloma urine, Multiple Myeloma blood, Sensitivity and Specificity, Immunoglobulin Light Chains blood, Immunoglobulin Light Chains urine, Isoelectric Focusing methods, Paraproteinemias urine, Paraproteinemias diagnosis, Paraproteinemias blood
- Abstract
Background: Isoelectric focusing (IEF) is a method with an exquisite resolution, and coupled with affinity immunoblotting (AIB), it can provide superior sensitivity to detect monoclonal free light chains (FLC)., Methods: We tested the hypothesis that IEF/AIB is more sensitive and specific for monoclonal FLC detection in serum and urine samples than conventional methods, that is, electrophoresis (ELP), immunofixation (IF) and serum FLC ratio assessment. Investigation included 107 samples of 68 patients, among which 21 multiple myeloma patients were recently tested for minimal residual disease and 18 patients with AL amyloidosis., Results: Monoclonal FLC were detected by IEF/AIB in 37% of serum samples negative for monoclonal FLC on ELP/IF. As for urine samples, significant advantage of the IEF/AIB over ELP/IF was not demonstrated. Considering both serum and urine results, IEF/AIB definitely revealed monoclonal FLC in 20/83 (24%) of ELP/IF-negative samples. FLC ratio was abnormally high (>1.65) in all 11 patients definitely positive for monoclonal FLC kappa by IEF/AIB but also in 16/47 (34%) IEF/AIB-negative samples. Abnormally low values (<0.26) were found only in 10/28 samples (36%) positive for monoclonal FLC lambda. Appropriate use of renal FLC ratio reference range reduced the number of presumably false positives (6/47, i.e. 13%) but not false negatives (17/28, i.e. 61%)., Conclusions: The IEF/AIB method is more sensitive than IF and might be used in patients with negative IF results before deciding whether to proceed to minimal residual disease testing., Competing Interests: Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
8. Characteristics of isatuximab-derived interference in serum protein electrophoresis and immunofixation, and an absence of sustained in vivo interference due to belantamab mafodotin and denosumab.
- Author
-
Jimenez A, Scholl AR, Wang B, Schilke M, and Carlsen ED
- Subjects
- Humans, Retrospective Studies, Blood Protein Electrophoresis methods, Female, Male, Aged, Middle Aged, Antibodies, Monoclonal, Immunoelectrophoresis methods, Denosumab therapeutic use, Antibodies, Monoclonal, Humanized therapeutic use, Multiple Myeloma drug therapy, Multiple Myeloma blood
- Abstract
Objectives: Some therapeutic monoclonal antibodies, like daratumumab and elotuzumab, produce interfering monoclonal bands on serum protein electrophoresis (SPEP) and immunofixation electrophoresis (IFE). Whether other common therapeutic antibodies also produce interference has not been systematically evaluated., Design and Methods: SPEP/IFE from patients receiving isatuximab (48 patients), belantamab mafodotin (BM; 41), and denosumab (41) were retrospectively reviewed for therapeutic antibody interference. Cases exhibiting isatuximab interference were quantified and the maximum duration of isatuximab effect was evaluated. To characterize band position, neat human serum was spiked with BM or denosumab at supratherapeutic concentrations. Band migration patterns were compared on SPEP and IFE, with band position expressed relative to other constant protein fractions., Results: Isatuximab-induced IFE interference was common (81.3 % of evaluated patients) with a maximum observed duration of 8 weeks. 10.4 % of isatuximab patients had IgG kappa monoclonal gammopathies that co-migrated with the drug; this subset could benefit from HYDRASHIFT 2/4 isatuximab testing. 8.3 % of IFE cases were negative for an isatuximab band but showed large, endogenous M-spikes migrating elsewhere. All patients in this group expired within 1 year of this finding. We hypothesize that an inability to detect isatuximab in this setting corresponds to a large residual myeloma burden that reduces isatuximab serum concentration. This observation may serve as a negative prognostic factor. Spiking studies demonstrated that BM and denosumab produce interference in vitro, but sustained interference was not observed in >40 treated patients., Conclusions: Therapeutic antibody interference in patients receiving isatuximab is common, and can persist for at least 8 weeks after administration. >10 % of patients receiving isatuximab may benefit from HYDRASHIFT testing post-therapy. In contrast, BM and denosumab fail to produce sustained interference in treated patients., (Copyright © 2024 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
9. Utilizing Mass Spectrometry to Detect and Isotype Monoclonal Proteins in Urine: Comparison to Electrophoretic Methods.
- Author
-
Moonen DH, Kohlhagen M, Dasari S, Willrich MA, Kourelis T, Dispenzieri A, and Murray DL
- Subjects
- Humans, Immunoglobulin kappa-Chains, Mass Spectrometry, Immunoelectrophoresis methods, Antibodies, Monoclonal, Immunoglobulin Light Chains, Paraproteinemias
- Abstract
Background: Matrix assisted laser desorption ionization time of flight mass spectrometry coupled to immune enrichment (MASS-FIX) as an alternative to serum immunofixation electrophoresis has demonstrated increased sensitivity in monoclonal protein (MP) detection with improved laboratory workflow. This study explored similar replacement of urine immunofixation electrophoresis (u-IFE) with urine MASS-FIX (u-MASS-FIX) by method comparison., Methods: Residual urine (n = 1008) from Mayo Clinic patients with a known plasma cell disease were assayed neat by u-MASS-FIX analysis. Each sample was paired with the following: u-IFE, urine total protein, urine protein electrophoresis, serum κ/λ free light chain (LC) ratio (rFLC), and serum MASS-FIX (s-MASS-FIX). Analytical sensitivities were measured in pooled urine spiked with daratumumab., Results: u-IFE and u-MASS-FIX had 91% agreement in determining the presence/absence of MPs (Cohen kappa = 0.8200). In discrepant cases, serum rFLC statistically aligned more closely with positive u-MASS-FIX cases than u-IFE. Patients positive by both s-MASS-FIX and u-MASS-FIX had matching MP masses (±20 daltons) in 94% of cases. The u-MASS-FIX spectra further identified κ/λ LC fragments and glycosylated LCs not appreciated on u-IFE. The unconcentrated u-MASS-FIX limit of detection of 0.156 mg/mL was determined equivalent to 100× concentrated u-IFE., Conclusion: u-MASS-FIX is a reliable alternative to u-IFE with the added benefits of LC glycosylation detection and MP mass tracking between serum and urine. Furthermore, u-MASS-FIX is performed using neat urine. Eliminating the need to concentrate urine for u-IFE has potential to increase productivity by decreasing labor minutes per test., (© American Association for Clinical Chemistry 2023.)
- Published
- 2023
- Full Text
- View/download PDF
10. Expert-Level Immunofixation Electrophoresis Image Recognition based on Explainable and Generalizable Deep Learning.
- Author
-
Hu H, Xu W, Jiang T, Cheng Y, Tao X, Liu W, Jian M, Li K, and Wang G
- Subjects
- Humans, Reproducibility of Results, Artificial Intelligence, Immunoelectrophoresis methods, Immunoglobulin A, Immunoglobulin G, Immunoglobulin M, Deep Learning, Paraproteinemias
- Abstract
Background: Immunofixation electrophoresis (IFE) is important for diagnosis of plasma cell disorders (PCDs). Manual analysis of IFE images is time-consuming and potentially subjective. An artificial intelligence (AI) system for automatic and accurate IFE image recognition is desirable., Methods: In total, 12 703 expert-annotated IFE images (9182 from a new IFE imaging system and 3521 from an old one) were used to develop and test an AI system that was an ensemble of 3 deep neural networks. The model takes an IFE image as input and predicts the presence of 8 basic patterns (IgA-, IgA-, IgG-, IgG-, IgM-, IgM-, light chain and ) and their combinations. Score-based class activation maps (Score-CAMs) were used for visual explanation of the models prediction., Results: The AI model achieved an average accuracy, sensitivity, and specificity of 99.82, 93.17, and 99.93, respectively, for detection of the 8 basic patterns, which outperformed 4 junior experts with 1 years experience and was comparable to a senior expert with 5 years experience. The Score-CAMs gave a reasonable visual explanation of the prediction by highlighting the target aligned regions in the bands and indicating potentially unreliable predictions. When trained with only the new system images, the models performance was still higher than junior experts on both the new and old IFE systems, with average accuracy of 99.91 and 99.81, respectively., Conclusions: Our AI system achieved human-level performance in automatic recognition of IFE images, with high explainability and generalizability. It has the potential to improve the efficiency and reliability of diagnosis of PCDs., (© American Association for Clinical Chemistry 2022. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2023
- Full Text
- View/download PDF
11. Mitigating the interference of Daratumumab with immunofixation electrophoresis. A single-center experience using Hydrashift 2/4 kit.
- Author
-
Duek A, Lellouche E, Ben Baruch S, Mashiach R, Segman Y, Bryk G, and Leiba M
- Subjects
- Male, Humans, Aged, Middle Aged, Immunoelectrophoresis methods, Immunoglobulin G, Electrophoresis, Immunoglobulin Light Chains, Multiple Myeloma diagnosis, Multiple Myeloma drug therapy
- Abstract
Background: Multiple myeloma (MM) accounts for approximately 10% of hematological malignancies. The monoclonal immunoglobulin G kappa (IgG-κ) daratumumab can bind to CD38 on MM cells and be detected in serum immunofixation (IF), causing pitfalls in M-protein quantification., Objectives: To determine the efficacy of mitigating the interference of IgG MM treated with daratumumab., Methods: Levels of Ig, free light chains (FLC) kappa (κ) and lambda (λ), serum protein electrophoresis (SPE)/IF, and Hydrashift 2/4 assays were assessed following manufacturer's instructions in three patients., Results: Patient 1 was a 70-year-old male diagnosed with IgG-λ MM. The IF distinguished two monoclonal bands (IgG-κ and IgG-λ). With the Hydrashift assay, the daratumumab-anti-daratumumab immune complex shifted the IgG-κ to the α zone, suggesting that the monoclonal IgG-κ band corresponded to daratumumab. Patient 2 was a 63-year-old male with IgG-κ MM who was receiving daratumumab once every other week. SPE/IF assay revealed a faint monoclonal IgG-κ band in the zone. A stronger monoclonal band was observed after administration. The IgG-κ band disappeared on the Hydrashift assay, while the daratumumab-anti-daratumumab complex appeared as a broad smear in the α-region. Patient 3, a 63-year-old male diagnosed with IgG-λMM, was receiving daratumumab once every other month. The IF assay showed two distinct bands (IgG-κ and IgG-λ) post-daratumumab administration. The shift to the α zone of the IgG-κ bands on the Hydrashift assay confirmed that the additional band observed post-infusion was due to the daratumumab., Conclusions: The Hydrashift assay can help distinguish daratumumab from endogenous M-spike.
- Published
- 2022
12. Monoclonal Immunoglobulin Associated with Monoclonal Free Light Chains Invisible on Capillary Electrophoresis.
- Author
-
Biaz A, Konzi K, Mahtat E, Elmachtaniidrissi S, Doghmi K, Dami A, and Bouhsain S
- Subjects
- Antibodies, Monoclonal, Electrophoresis, Capillary methods, Humans, Immunoelectrophoresis methods, Immunoglobulin kappa-Chains, Immunoglobulin lambda-Chains, Immunoglobulin Light Chains, Paraproteinemias diagnosis
- Abstract
Background: We report the case of a monoclonal immunoglobulin of IgM Lambda isotype associated with monoclonal lambda-type free light chains not detected by capillary electrophoresis but identified by immunofixation., Methods: Capillary electrophoresis showed hypoproteinemia and an inflammatory syndrome. The IF realized on Hydrasys 2 Scan Focusing Sebia® reveals an IgM monoclonal band and two monoclonal bands in the total lambda. A second IF is performed using anti IgM, anti IgD, anti IgE and anti-total and -free lambda light chains as antisera. It reveals the presence of a monoclonal protein isotype IgM Lambda with free light chains. In view of these discordant results, an immunosubtraction was performed on the same sample showing no abnormality., Results: Our patient has a monoclonal IgM Lambda with lambda monoclonal free light chains all masked on capillary electrophoresis and therefore not detected., Conclusions: Capillary electrophoresis techniques are incrementally becoming the techniques of choice in medical laboratories as a replacement for gel electrophoresis, due to their automation and better sensitivity. However, in some cases, a monoclonal immunoglobulin may not be detected by capillary technique and may cause an inaccurate interpretation.
- Published
- 2022
- Full Text
- View/download PDF
13. MALDI-TOF mass spectrometry can distinguish immunofixation bands of the same isotype as monoclonal or biclonal proteins.
- Author
-
Fatica EM, Martinez M, Ladwig PM, Murray JD, Kohlhagen MC, Kyle RA, Kourelis T, Lust JA, Snyder MR, Dispenzieri A, Murray DL, and Willrich MAV
- Subjects
- Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal chemistry, Female, Humans, Immunoglobulin G blood, Immunoglobulin G chemistry, Male, Middle Aged, Multiple Myeloma blood, Myeloma Proteins chemistry, Protein Multimerization, Spectrometry, Mass, Electrospray Ionization, Antibodies, Monoclonal blood, Immunoelectrophoresis methods, Myeloma Proteins analysis, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization methods
- Abstract
Background: Plasma cell disorders (PCDs) are typically characterized by excessive production of a single immunoglobulin, defined as a monoclonal protein (M-protein). Some patients have more than one identifiable M-protein, termed biclonal. Traditional immunofixation electrophoresis (IFE) cannot distinguish if two bands of the same isotype represent biclonal proteins or M-proteins with some other feature. A novel assay using immunoenrichment coupled to matrix-assisted laser desorption ionization time-of-flight mass-spectrometry (Mass-Fix) was applied to determine whether two bands of the same isotype represented (1) monomers and dimers of a single M-protein, (2) an M-protein plus a therapeutic monoclonal antibody (t-mAb), (3) an M-protein with light chain glycosylation, or (4) two distinct biclonal M-proteins., Methods: Patient samples with two bands of the same isotype identified by IFE were enriched using nanobodies against IgG, IgA, IgM, or κ and λ light chains then analyzed by Mass-Fix. Light chain masses were used to differentiate IgGκ M-proteins from t-mAbs. Mass differences between peaks were calculated to identify N-glycosylation or matrix adducts. High-resolution mass spectrometry was used as a comparator method in a subset of samples., Results: Eighty-one residual samples were collected. For IgA, 93% (n = 25) were identified as monoclonal. For IgG, 67% (n = 24) were monoclonal, and 33% (n = 12) were truly biclonal. Among the monoclonal IgGs, the second band represented a glycosylated form for 21% (n = 5), while 33% (n = 8) had masses consistent with a t-mAb. 44% (n = 8) of IgM samples were biclonal, and 56% (n = 10) were monoclonal, of which one was glycosylated., Conclusions: We demonstrate the utility of mass spectrometry in the characterization of multiple IFE bands of the same isotype. Improved reporting accuracy of M-proteins is useful for monitoring of patients with PCDs., (Copyright © 2021 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
14. C3dg Quantification by PEG Precipitation and or TRIFMA.
- Author
-
Troldborg A and Jensenius JC
- Subjects
- Animals, Biomarkers analysis, Biomarkers blood, Blood Protein Electrophoresis, Complement Activation physiology, Complement C3b isolation & purification, Enzyme-Linked Immunosorbent Assay methods, Fluoroimmunoassay methods, Humans, Immunoelectrophoresis methods, Inflammation blood, Inflammation diagnosis, Inflammation Mediators analysis, Inflammation Mediators blood, Peptide Fragments isolation & purification, Polyethylene Glycols chemistry, Rabbits, Chemical Precipitation, Complement C3b analysis, Fluorescent Antibody Technique methods, Peptide Fragments analysis
- Abstract
Detection of complement activation products can be carried out in a number of ways, and different methods are used in different laboratories. No international standard for measuring complement activation in the clinical setting has been agreed upon.Here we describe a modified assay for measuring C3dg. The assay is simple, inexpensive and stable. The estimation of C3dg directly reflects complement turnover independently of activation pathway.
- Published
- 2021
- Full Text
- View/download PDF
15. Quantification of Complement Proteins with Special Reference to C1q: Multiplex Versus ELISA Versus Rocket Immunoelectrophoresis Versus Nephelometry.
- Author
-
Sandholm K, Persson B, Abdalla S, Mohlin C, Nilsson B, and Ekdahl KN
- Subjects
- Blood Protein Electrophoresis methods, Diagnostic Tests, Routine methods, Enzyme-Linked Immunosorbent Assay methods, Humans, Immunomagnetic Separation methods, Complement C1q analysis, Complement System Proteins analysis, Immunoelectrophoresis methods, Nephelometry and Turbidimetry methods
- Abstract
Accurate determination of complement component C1q is hampered by the fact that C1q is an immune complex binding protein. Consequently, immunochemical techniques which rely on immune complex formation in fluid phase such as nephelometry and turbidimetry tend to give results which differ from those obtained by, for example, ELISA and other solid phase-based assays. In this chapter, we discuss the pros and cons of different techniques for the quantification of C1q and present a comprehensive protocol for a newly developed magnetic bead-based sandwich immunoassay which has replaced nephelometry in our complement diagnostic laboratory at the University Hospital in Uppsala.
- Published
- 2021
- Full Text
- View/download PDF
16. Quantification by Ultrafiltration and Immunofixation Electrophoresis Testing for Monoclonal Serum Free Light Chains.
- Author
-
Singh G and Bollag R
- Subjects
- Biomarkers, Humans, Immunoglobulin kappa-Chains blood, Immunoglobulin lambda-Chains blood, Multiple Myeloma blood, Multiple Myeloma diagnosis, Sensitivity and Specificity, Antibodies, Monoclonal blood, Immunoelectrophoresis methods, Immunoelectrophoresis standards, Immunoglobulin Light Chains blood, Ultrafiltration methods, Ultrafiltration standards
- Abstract
Objective: Measurement of monoclonal immunoglobulins is a reliable estimate of the plasma cell tumor mass. About 15% of plasma cell myelomas secrete light chains only. The concentration of serum free light chains is insufficient evidence of the monoclonal light chain burden. A sensitive quantitative estimate of serum free monoclonal light chains could be useful for monitoring patients with light chain myeloma. We describe such an assay that does not require mass-spectrometry equipment or expertise., Methods: Serum specimens from patients with known light chain myelomas and controls were subjected to ultrafiltration through a membrane with pore size of 50 kDa. The filtrate was concentrated and tested by immunofixation electrophoresis. The relative area under the monoclonal peak, compared to that of the total involved light chain composition, was estimated by densitometric scanning of immunofixation gels. The proportion of the area occupied by the monoclonal peak in representative densitometric scans was used to arrive at the total serum concentration of the monoclonal serum free light chains., Results: Using an ultracentrifugation and concentration process, monoclonal serum free light chains were detectable, along with polyclonal light chains, in all 10 patients with active light chain myelomas. Monoclonal light chains were identified in serum specimens that did not reveal monoclonal light chains by conventional immunofixation electrophoresis. The limit of detection by this method was 1.0 mg/L of monoclonal serum free light chains., Conclusion: The method described here is simple enough to be implemented in academic medical center clinical laboratories and does not require special reagents, equipment, or expertise. Even though urine examination is the preferred method for the diagnosis of light chain plasma cell myelomas, measurement of the concentration of serum free light chains provides a convenient, albeit inadequate, way to monitor the course of disease. The method described here allows effective electrophoretic differentiation of monoclonal serum free light chain from polyclonal serum free light chains and provides a quantitation of the monoclonal serum free light chains in monitoring light chain monoclonal gammopathies., (© American Society for Clinical Pathology 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2020
- Full Text
- View/download PDF
17. Pseudomonas aeruginosa antibody response in cystic fibrosis decreases rapidly following lung transplantation.
- Author
-
Schwensen HF, Moser C, Perch M, Pressler T, and Høiby N
- Subjects
- Adult, Chronic Disease, Denmark epidemiology, Female, Humans, Immunoelectrophoresis methods, Immunologic Memory immunology, Male, Postoperative Period, Retrospective Studies, Antibodies, Bacterial analysis, Antibodies, Bacterial blood, Antibody Formation immunology, Cystic Fibrosis epidemiology, Cystic Fibrosis immunology, Cystic Fibrosis microbiology, Cystic Fibrosis surgery, Lung Transplantation methods, Pseudomonas Infections blood, Pseudomonas Infections physiopathology, Pseudomonas aeruginosa immunology
- Abstract
Background: Specific Pseudomonas aeruginosa (PA) precipitating immunoglobulin G antibodies in serum are correlated with PA biofilm infection and are used as diagnostic and prognostic markers in cystic fibrosis (CF). The aim of this study was to examine the change of PA antibody response in CF patients after bilateral sequential lung transplantation (LTx)., Methods: PA antibodies and airway bacteriology were retrospectively evaluated in 20 chronically infected CF patients, who underwent LTx between 2001 and 2016 at Rigshospitalet, Copenhagen. Yearly precipitin counts from one year before LTx and up to five years after LTx were compared. Monthly airway cultures were examined in the five-year period after LTx. In addition, crossed immunoelectrophoresis (CIE) were analysed for each patient for antigenic similarities from time of infection, pre-LTx and post-LTx., Results: All patients experienced a significant drop in PA antibodies from one year pre-LTx to one year post-LTx (p < 0.0001). The PA antibody level did not differ between those, who became reinfected immediately after LTx, and those, who did not. No patients regained the high pre-LTx precipitin levels in the following five years. The antigenic specificities of the sera post-LTx were in each patient similar to the antigenic specificities at the beginning of infection indicating a decades long memory of their immune response like an "immunological fingerprint"., Conclusions: After LTx a significant and continuous reduction in PA antibodies was observed. The reduction was independent of immediate reinfection after LTx. A novel three-factor explanatory model is presented., Competing Interests: Declaration of Competing Interest CM is funded by the Novo Nordic Foundation Borregaard Clinical Scientist Fellowship Grant # NNF17OC00250074. The rest of the authors did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors., (Copyright © 2020. Published by Elsevier B.V.)
- Published
- 2020
- Full Text
- View/download PDF
18. Performance comparison of EasyFix G26 and HYDRASYS 2 SCAN for the detection of serum monoclonal proteins.
- Author
-
Amin Nordin FD, Mohd Khalid MKN, Abdul Aziz SM, Mohamad Bakri NA, Ahmad Ridzuan SN, Abdul Jalil J, Habib A, and Yakob Y
- Subjects
- Automation, Laboratory, Blood Protein Electrophoresis methods, Blood Proteins immunology, Humans, Immunoelectrophoresis methods, Myeloma Proteins analysis, Reproducibility of Results, Blood Protein Electrophoresis instrumentation, Blood Proteins analysis, Immunoelectrophoresis instrumentation
- Abstract
Background: Serum protein electrophoresis (SPE) is a widely used laboratory technique to diagnose patients with multiple myeloma (MM) and other disorders related to serum protein. In patients with MM, abnormal monoclonal protein can be detected by SPE and further characterized using immunofixation electrophoresis (IFE). There are several semi-automated agarose gel-based systems available commercially for SPE and IFE. In this study, we sought to evaluate the analytical performance of fully automated EasyFix G26 (EFG26) and semi-automated HYDRASYS 2 SCAN (H2SCAN) for both SPE and IFE., Methods: Both instruments were operated according to manufacturer's instructions. Samples used include a commercially available normal control serum (NCS) and patients' specimens. The following were evaluated: precision and comparison studies for SPE, and reproducibility and comparison studies for IFE. Statistical analyses were performed using Microsoft Excel., Results: For SPE repeatability study, our results showed that EFG26 has higher coefficient of variation (%CV) compared with H2SCAN for both samples except for monoclonal component with %CV of 0.97% and 1.18%, respectively. Similar results were obtained for SPE reproducibility study except for alpha-1 (4.16%) and beta (3.13%) fractions for NCS, and beta fractions (5.36%) for monoclonal sample. Subsequently, reproducibility for IFE was 100% for both instruments. Values for correlation coefficients between both instruments ranged from 0.91 to 0.98 for the five classic bands., Conclusion: Both instruments demonstrated good analytical performance characterized by high precision, reproducibility and correlation., (© 2020 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals, Inc.)
- Published
- 2020
- Full Text
- View/download PDF
19. Flucloxacillin-Induced Hepatotoxicity - Association with HLA-B*5701.
- Author
-
Teixeira M, Macedo S, Batista T, Martins S, Correia A, and Matos LC
- Subjects
- Aged, Chemical and Drug Induced Liver Injury enzymology, Humans, Immunoelectrophoresis methods, Liver drug effects, Liver pathology, Male, Risk Factors, Chemical and Drug Induced Liver Injury etiology, Chemical and Drug Induced Liver Injury pathology, Floxacillin adverse effects, HLA-B Antigens drug effects
- Abstract
Drug-induced liver injury (DILI) to flucloxacillin is rare and is classified as idiosyncratic, as it is dependent on individual susceptibility, unpredictable, and dose-independent. The authors present the case of a 74 - year - old man with a history of monoclonal gammopathy under investigation and alcoholic habits of 24 g/day, with asthenia, anorexia, nausea, abdominal discomfort, and fever with three days of evolution. He was treated with two courses of antibiotic therapy with flucloxacillin to erysipelas previously (3 months and 2 weeks before admission). Lab tests showed serum AST levels of 349 U/L, ALT 646 U/L, alkaline phosphatase 302 U/L, GGT 652 U/L, total bilirubin 3.3 mg/dL and direct bilirubin 2.72 mg/dL. Infectious, autoimmune, and metabolic causes were ruled out. Magnetic resonance cholangiopancreatography showed normal results. Liver biopsy showed mild multifocal (predominantly microvesicular) steatosis; marked changes in the centrilobular areas (sinusoidal dilatation, marked congestion, hemorrhage, and multifocal hepatocyte collapse); expansion of the portal areas with the formation of bridges; proliferated bile ducts and inflammatory infiltrate of variable density, predominantly mononuclear type. The HLA-B*5701 screening test was positive. Hepatic biochemical tests remain abnormal with a significative increase in total bilirubin, which reached levels of 24.1 mg/dL, with the development of jaundice, pruritus, and choluria. DILI was assumed, and the patient was treated with ursodeoxycholic acid. There was favorable evolution, without evidence of blood coagulation dysfunction or encephalopathy. The analytic normalization was, however, slow, with evolution to chronicity. The authors present this case to remind the possibility of moderate/severe drug-induced liver injury to flucloxacillin, an antibiotic commonly used in clinical practice and association with the HLA-B * 5701 allele reported in the literature.
- Published
- 2020
- Full Text
- View/download PDF
20. Incidence and Management of Therapeutic Monoclonal Antibody Interference in Monoclonal Gammopathy Monitoring.
- Author
-
Liu L, Wertz WJ, Kondisko A, Shurin MR, and Wheeler SE
- Subjects
- Blood Protein Electrophoresis methods, Humans, Immunoelectrophoresis methods, Immunologic Factors analysis, Immunologic Factors pharmacokinetics, Immunologic Factors therapeutic use, Limit of Detection, Reproducibility of Results, Antibodies, Monoclonal analysis, Antibodies, Monoclonal immunology, Antibodies, Monoclonal pharmacokinetics, Antibodies, Monoclonal therapeutic use, Antibodies, Monoclonal, Humanized analysis, Antibodies, Monoclonal, Humanized pharmacokinetics, Antibodies, Monoclonal, Humanized therapeutic use, Diagnostic Errors prevention & control, Immunoglobulin Light Chains analysis, Multiple Myeloma blood, Multiple Myeloma diagnosis, Multiple Myeloma drug therapy
- Abstract
Background: The treatment of multiple myeloma (MM) has been revolutionized by the introduction of therapeutic monoclonal antibodies (tmAbs). Daratumumab, a human IgG1/κ tmAb against CD38 on plasma cells, has improved overall survival in refractory MM and was recently approved as a frontline therapy for MM. Work on tmAb interference with serum protein electrophoresis (SPE) during MM monitoring has failed to provide information for laboratories on incidence of interference and effective methods of managing the interference at a practicable level. We aimed to evaluate daratumumab and elotuzumab interference in a large academic hospital setting and implement immediate solutions., Methods: We identified and chart reviewed all cases of possible daratumumab interference by electrophoretic pattern (120 of 1317 total cases over 3 months). We retrospectively reviewed SPE cases in our laboratory to assess clinical implications of tmAb interference before the laboratory was aware of tmAb treatment. We supplemented samples with daratumumab and elotuzumab to determine the limits of detection and run free light chain analysis., Results: Approximately 9% (120 of 1317) of tested cases have an SPE and/or immunofixation electrophoresis (IFE) pattern consistent with daratumumab, but only approximately 47% (56) of these cases were associated with daratumumab therapy. Presence of daratumumab led to physician misinterpretation of SPE/IFE results. Limits of daratumumab detection varied with total serum gammaglobulin concentrations, but serum free light chain analysis was unaffected., Conclusions: Clinical laboratories currently rely on interference identification by electrophoretic pattern, which may be insufficient and is inefficient. Critical tools in preventing misinterpretation efficiently include physician education, pharmacy notifications, separate order codes, and interpretive comments., (© 2019 American Association for Clinical Chemistry.)
- Published
- 2020
- Full Text
- View/download PDF
21. A Puzzling Case of Hyperviscosity Syndrome.
- Author
-
Taher J, Chen C, and Kulasingam V
- Subjects
- Aged, 80 and over, Bone Marrow Examination methods, Diagnosis, Differential, Female, Humans, Immunoelectrophoresis methods, Immunologic Factors administration & dosage, Multiple Myeloma diagnosis, Rheumatoid Factor blood, Treatment Outcome, Blood Viscosity immunology, Immunoglobulin M blood, Plasma Exchange methods, Rituximab administration & dosage, Waldenstrom Macroglobulinemia blood, Waldenstrom Macroglobulinemia diagnosis, Waldenstrom Macroglobulinemia physiopathology, Waldenstrom Macroglobulinemia therapy
- Published
- 2020
- Full Text
- View/download PDF
22. Better Resolution of Gel Electrophoresis than that of Capillary Electrophoresis: About a Case Report.
- Author
-
Biaz A, Raiss C, El-Amin G, Uwingabiye J, El-Machtani-Idrissi S, Dami A, Ouzzif Z, and Bouhsain S
- Subjects
- Antibody Specificity immunology, Blood Protein Electrophoresis methods, Humans, Immunoelectrophoresis methods, Immunoglobulin G analysis, Immunoglobulin kappa-Chains analysis, Paraproteinemias immunology, Reproducibility of Results, Electrophoresis, Agar Gel methods, Electrophoresis, Polyacrylamide Gel methods, Paraproteinemias metabolism
- Published
- 2019
- Full Text
- View/download PDF
23. Challenges in Interpreting Multiple Monoclonal Bands on Serum Protein Electrophoresis and Serum Immunofixation Electrophoresis: An Illustrative Case Report.
- Author
-
Larsen R, Allen S, Thompson TZ, Bollag R, and Singh G
- Subjects
- Aged, Antibodies, Monoclonal analysis, Antibodies, Monoclonal blood, Biomarkers, Blood Viscosity, Female, Humans, Waldenstrom Macroglobulinemia blood, Waldenstrom Macroglobulinemia diagnosis, Blood Proteins analysis, Electrophoresis methods, Immunoelectrophoresis methods
- Published
- 2019
- Full Text
- View/download PDF
24. Isotyping of Paraprotein Irresolvable by Routine Immunofixation Electrophoresis.
- Author
-
Liu H, Wilburn C, and Yi X
- Subjects
- Aged, Biomarkers, Tumor analysis, Humans, Male, Waldenstrom Macroglobulinemia blood, Immunoelectrophoresis methods, Myeloma Proteins analysis, Paraproteins analysis, Waldenstrom Macroglobulinemia diagnosis
- Published
- 2019
- Full Text
- View/download PDF
25. Prozone effect observed for heavy chain α in the serum immunofixation electrophoresis of a patient with monoclonal IgA-λ gammopathy.
- Author
-
Enko D and Kriegshäuser G
- Subjects
- Aged, 80 and over, Albuminuria diagnosis, Antigen-Antibody Complex chemistry, Female, Humans, Immunoelectrophoresis methods, Immunoglobulin alpha-Chains blood, Paraproteinemias diagnosis
- Published
- 2019
- Full Text
- View/download PDF
26. The Lipemia Index: An Underutilized Tool to Detect Monoclonal Proteins.
- Author
-
Agrawal YP and Hall K
- Subjects
- Diagnostic Errors prevention & control, Humans, Immunoelectrophoresis methods, Multiple Myeloma diagnosis, Procedures and Techniques Utilization, Blood Chemical Analysis methods, Hyperlipidemias blood, Hyperlipidemias diagnosis, Multiple Myeloma blood, Myeloma Proteins analysis
- Published
- 2019
- Full Text
- View/download PDF
27. Gelation of Monoclonal Protein Was the Cause of Interference with a Total Bilirubin Assay.
- Author
-
Song L, Tong KH, and Chin CD
- Subjects
- Female, Humans, Immunoglobulin M analysis, Immunoglobulin M blood, Middle Aged, Specimen Handling methods, Bilirubin analysis, Bilirubin blood, Blood Protein Electrophoresis methods, Immunoelectrophoresis methods, Multiple Myeloma blood, Myeloma Proteins analysis, Myeloma Proteins chemistry
- Published
- 2019
- Full Text
- View/download PDF
28. Value of Urinary Free Light Chain Testing for Monitoring of Bence Jones Proteinuria.
- Author
-
Delgado JC
- Subjects
- Female, Humans, Immunoglobulin Light Chains analysis, Immunoglobulin Light Chains urine, Male, Middle Aged, Monitoring, Physiologic methods, Proteinuria etiology, Urinalysis methods, Bence Jones Protein analysis, Immunoelectrophoresis methods, Multiple Myeloma diagnosis, Multiple Myeloma urine, Proteinuria diagnosis
- Published
- 2019
- Full Text
- View/download PDF
29. Distinguishing Drug from Disease by Use of the Hydrashift 2/4 Daratumumab Assay.
- Author
-
Thoren KL, Pianko MJ, Maakaroun Y, Landgren CO, and Ramanathan LV
- Subjects
- Aged, Aged, 80 and over, Antibodies, Monoclonal therapeutic use, Antineoplastic Agents pharmacology, False Positive Reactions, Female, Humans, Male, Middle Aged, Multiple Myeloma blood, Multiple Myeloma pathology, Myeloma Proteins immunology, Antibodies, Monoclonal immunology, Immunoassay methods, Immunoelectrophoresis methods, Multiple Myeloma drug therapy, Multiple Myeloma immunology, Myeloma Proteins analysis
- Abstract
Background: Daratumumab, a monoclonal antibody used to treat relapsed or refractory multiple myeloma, can interfere with protein electrophoresis and immunofixation assays. False-positive immunofixation results due to daratumumab can cause uncertainty regarding the status of a patient's disease and lead to potential misclassification of their response to therapy. The Hydrashift 2/4 Daratumumab assay (Sebia) was recently cleared by the Food and Drug Administration for resolving daratumumab interference on immunofixation. Here, we evaluate the performance of the Hydrashift assay in multiple myeloma patients receiving treatment with daratumumab-based regimens., Methods: Waste serum samples from multiple myeloma patients (n = 40) receiving daratumumab were analyzed by standard immunofixation and the Hydrashift assay. Results from these tests were compared and were evaluated along with pretreatment serum protein electrophoresis and immunofixation results, if available., Results: The Hydrashift assay shifted the migration of daratumumab in patient samples. In 27 cases, the patient's M protein was distinguishable from daratumumab by standard immunofixation. In these cases, the Hydrashift assay confirmed that the IgGκ band was daratumumab and helped identify the presence of treatment-related oligoclonal bands. There were 11 instances in which the patient's IgGκ M protein comigrated with daratumumab. In all 11 cases, the Hydrashift assay confirmed the presence of residual M protein. Finally, in 2 patients whose pretreatment immunofixation results were not available, the Hydrashift assay confirmed that the IgGκ band visible on immunofixation was due to daratumumab alone., Conclusions: The Hydrashift 2/4 Daratumumab assay is a useful tool to clarify the source of an IgGκ band on immunofixation and allow a patient's M protein to be viewed without interference., (© 2018 American Association for Clinical Chemistry.)
- Published
- 2019
- Full Text
- View/download PDF
30. The FLC dimer with lambda type may false-migrate to the position of "albumin" band by urine protein electrophoresis on Sebia agarose gel-based detection system.
- Author
-
Chen C, Chen P, and Fang X
- Subjects
- Aged, Bence Jones Protein urine, Cohort Studies, Disulfides chemistry, Female, Humans, Immunoglobulin Light Chains urine, Male, Middle Aged, Bence Jones Protein chemistry, Electrophoresis, Polyacrylamide Gel methods, Immunoelectrophoresis methods, Immunoglobulin Light Chains chemistry, Multiple Myeloma urine, Proteinuria urine
- Abstract
Background: Monoclonal free light chains (FLC) commonly exist in monomeric or dimeric forms but rarely as larger molecules. Little is known about whether polymeric molecules can affect urine protein electrophoresis (UPE) results., Methods: Urine samples were collected from 72 multiple myeloma (MM) patients with Bence Jones protein (BJP). Urine protein and immunofixation electrophoresis were analyzed on Sebia SDS "agarose" gel electrophoresis system (SDS-AGE), and immunoglobulin free light chains were measured on the BNII nephelometric assay., Results: A type of disulfide-bound FLC dimer shows a pattern shift to the position of the "albumin" band in urine protein electrophoresis in multiple myeloma (MM) patients according to the Sebia agarose gel-based detection system, which was validated by immunofixation, SDS-PAGE, and mass spectrometric methods. Similar cases were found in 21 (29.17%) of 72 MM patients with BJP, and 19 (90.5%) of 21 patients were the lambda type., Conclusions: These results indicate that BJP with lambda type has a strong tendency to abnormally migrate, which may increase the risk of misinterpretation of protein electrophoresis in clinics. Thus, when the urine protein electrophoresis is inconsistent with the result by nephelometric method, urine protein electrophoresis needs to be repeated on the deduced condition to confirm the essence of the originally identified "albumin.", (© 2018 Wiley Periodicals, Inc.)
- Published
- 2019
- Full Text
- View/download PDF
31. Evaluation of a Novel Immunoassay for Quantification of C1q for Clinical Diagnostic Use.
- Author
-
Sandholm K, Persson B, Skattum L, Eggertsen G, Nyman D, Gunnarsson I, Svenungson E, Nilsson B, and Ekdahl KN
- Subjects
- Antibodies, Monoclonal, Autoantibodies blood, Biomarkers analysis, Biomarkers cerebrospinal fluid, Complement C1q immunology, Data Accuracy, Edetic Acid, Enzyme-Linked Immunosorbent Assay methods, Humans, Immunoelectrophoresis methods, Lupus Nephritis blood, Lupus Nephritis cerebrospinal fluid, Magnetic Fields, Nephelometry and Turbidimetry methods, Severity of Illness Index, Complement C1q analysis, Complement C1q cerebrospinal fluid, Immunomagnetic Separation methods, Lupus Erythematosus, Systemic blood, Lupus Erythematosus, Systemic cerebrospinal fluid
- Abstract
Objectives: C1q is a valuable biomarker of disease activity in systemic lupus erythematosus (SLE). The "gold standard" assay, rocket immunoelectrophoresis (RIE), is time-consuming, and thus a shift to soluble immune precipitation techniques such as nephelometry has occurred. However, quantification of C1q with these techniques has been questioned as a result of the antibody binding properties of C1q. In the present work, we have compared results using various techniques (RIE, nephelometry, and ELISA) and have developed and validated a new magnetic bead-based sandwich immunoassay (MBSI). Methods: C1q was quantified by nephelometry and the new sandwich immunoassay in 45 serum samples analyzed using RIE. C1q was also assessed in plasma using RIE and sandwich immunoassay in samples from SLE patients with nephritis ( n = 69), SLE patients without nephritis ( n = 310) as classified by BILAG score, and matched controls ( n = 322). In addition, cerebrospinal fluid (CSF) samples from 31 patients, previously analyzed with ELISA, were also analyzed with the MBSI to test the behavior of this new assay in the lower detection range. Results: We found a strong correlation between the new MBSI, RIE, and ELISA, but not with nephelometry. The MBSI demonstrated lower levels of C1q in SLE patients than in matched controls ( p < 0.0001), and patients with nephritis had lower levels than patients without nephritis ( p < 0.01). Similarily, RIE showed significant differences between the patient groups ( p < 0.0001). An association was also found between the levels of C1q and the SLE disease activity index (SLEDAI). Furthermore, there was good correlation between the values obtained by MBSI and ELISA, in both serum ( r = 0.960) and CSF ( r = 0.786), underscoring the ability of both techniques to measure low concentrations of C1q with high accuracy. Conclusion: The sandwich immunoassay correlated well with RIE, but soluble immune precipitation techniques, such as nephelometry, did not appear suitable alternatives, since C1q itself, and possibly anti-C1q antibodies, interfered with the measurements. The new sandwich immunoassay is therefore a good replacement for RIE in monitoring SLE disease activity.
- Published
- 2019
- Full Text
- View/download PDF
32. Identification of the Antigen Content of Electroimmunoprecipitates.
- Author
-
Beyer NH and Heegaard NHH
- Subjects
- Animals, Humans, Mass Spectrometry, Antibodies analysis, Antigens analysis, Immunoelectrophoresis methods, Immunoprecipitation methods
- Abstract
Polyclonal antibodies including purified antibody fractions and animal or human antisera may react with unknown antigens or antigens other than their main specificity in reactions that are best visualized by gel electroimmunoprecipitation methods (e.g., when analyzing complex antigen mixtures). The great advantage of gel immunoprecipitation approaches is that each immunoprecipitate contains antigen in a pure form and that the precipitate is separated by position, shape, and size from other precipitates in the complex patterns of crossed immunoelectrophoresis. The identification of the antigen content of such immunoprecipitates is important but challenging because of the very stable, high-affinity complex formation leading to precipitation in the gels. Here, we present detailed step-by-step recipes for identifying the antigen content of electroimmunoprecipitates.
- Published
- 2019
- Full Text
- View/download PDF
33. Immunoelectrophoresis: A Method with Many Faces.
- Author
-
Csako G
- Subjects
- Amido Black chemistry, Animals, Antibodies chemistry, Coloring Agents chemistry, Electrophoresis, Agar Gel economics, Electrophoresis, Agar Gel instrumentation, Electrophoresis, Agar Gel methods, Equipment Design, Humans, Immunodiffusion economics, Immunodiffusion instrumentation, Immunodiffusion methods, Immunoelectrophoresis economics, Immunoelectrophoresis instrumentation, Rabbits, Blood Proteins analysis, Immunoelectrophoresis methods
- Abstract
Immunoelectrophoresis (IEP) was the first practical method that combined electrophoresis and immunoprecipitation for identifying and characterizing proteins within complex mixtures. Over the years, IEP has been extended to include a variety of techniques and, as a general name, has been applied to virtually any technique that involves electrophoresis and antigen-antibody precipitin reaction for proteins. Because of the diversity in technical details of different IEP versions, the method described here deals only with classic IEP. Although it requires some manual expertise, IEP is versatile, relatively easy to customize, and economical with no need for expensive instrumentation. Further, it can discern identity, partial identity, and nonidentity of the proteins. Any low-viscosity body fluid specimen or, possibly, culture fluid and tissue extract could be tested with IEP if proper antibodies are available. With these attributes, classic IEP remains a valuable tool for clinical diagnostic testing, purity checking of biochemical and pharmaceutical products, and research.
- Published
- 2019
- Full Text
- View/download PDF
34. [Renal failure revealing multiple myeloma with preexisting lesions on radiological images].
- Author
-
Bouchemla N, Nadri A, Chettati M, Fadili W, and Laouad I
- Subjects
- Chest Pain etiology, Cyclophosphamide administration & dosage, Dexamethasone administration & dosage, Dyspnea etiology, Female, Humans, Immunoelectrophoresis methods, Middle Aged, Multiple Myeloma drug therapy, Multiple Myeloma pathology, Renal Insufficiency physiopathology, Severity of Illness Index, Thalidomide administration & dosage, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Multiple Myeloma diagnosis, Renal Insufficiency etiology
- Abstract
The study involved a 54-year old female patient admitted with severe renal failure. She had a 1-month history of progressive stage II dyspnoea associated with chest pain, bone pain and anuria. Clinical examination showed hypertension (160/80mmHg), glomerular disease (urinary protein excretion 2+, blood 2+ and diuresis 300 cc). Pleuropulmonary examination showed diffuse bilateral lower-chest crackling sounds. Laboratory tests objectified severe renal failure with creatinine level 107mg, urea 1.65g/l, hyperkalaemia 7.8 mmol/l, CRP value 78mg/l, normochromic normocytic anemia with hemoglobin concentration 5.7g/dl and leukocytosis 13570 without thrombocytopenia, hyperprotidemia 144g/l, normal serum albumin concentration 33g/l, hypercalcemia 116mg/l and hyperphosphataemia 120mg/l. Serum protein electrophoresis showed monoclonal gamma globulin peak 60 g/l. Immunoelectrophoresis of plasma proteins showed IgG kappa gammapathy. Bence-Jones protein urine test was negative. Myelogram showed plasmocytosis 10%. Profile skull x-rays objectified multiple pre-existing geodes. The patient underwent CDT1 protocol with dexamethazone thalidomide 100 mg and oral endoxan.
- Published
- 2018
- Full Text
- View/download PDF
35. Monoclonal gammopathies regardless of subtypes are associated with poor prognosis of diffuse large B-cell lymphoma: A STROBE-compliant article.
- Author
-
Zhang Y, Wei Z, Li J, Gao R, and Liu P
- Subjects
- Antibodies, Monoclonal, Murine-Derived therapeutic use, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Case-Control Studies, Cyclophosphamide therapeutic use, Doxorubicin therapeutic use, Female, Humans, Immunoelectrophoresis methods, Lymphoma, Large B-Cell, Diffuse drug therapy, Lymphoma, Large B-Cell, Diffuse immunology, Lymphoma, Large B-Cell, Diffuse mortality, Male, Middle Aged, Paraproteinemias diagnosis, Prednisone therapeutic use, Prognosis, Retrospective Studies, Rituximab, Vincristine therapeutic use, Lymphoma, Large B-Cell, Diffuse complications, Paraproteinemias complications
- Abstract
Monoclonal gammopathy (MG), a positive result of serum immunofixation electrophoresis (SIFE), has been reported in cases of diffuse large B-cell lymphoma (DLBCL). We performed this study to further investigate the prognostic value of MG in DLBCL.We retrospectively reviewed patients diagnosed with DLBCL between January 2007 and December 2014, and identified 37 patients with MG. The clinical characteristics of these patients were then reviewed. A 1:2 case-control analysis was conducted on 74 matched controls, who were patients with DLBCL and without MG. Both cases and controls were age-matched and were diagnosed within the same year.Among 37 DLBCL patients with MG, the monoclonal component of IgM was the most frequent compared to the other subtypes. Laboratory tests showed that the presence of MG was correlated with a decreased platelet-to-lymphocyte ratio (PLR). Survival analysis showed that MG-secreting DLBCL patients had an inferior overall survival (OS) and progression-free survival (PFS), compared with MG-nonsecreting patients, regardless of MG subtype. However, treatment response analysis showed that MG was not a good indicator for tumor relapse. When patients with DLBCL were grouped by immunophenotype, we found that MG was associated with poor prognosis in the non-germinal center B-cell-like (GCB) type, rather than GCB type in OS analysis. Meanwhile, there was no statistical significance upon PFS analysis in both immunophenotypes. Furthermore, our study found that the appearance of MG during treatment did make prognostic sense compared to nonsecretors.Overall, MG can serve as a prognostic factor for DLBCL. We hypothesize that its presence in DLBCL may reflect the immune microenvironment in tumor progression and warrants further study to unveil the underlying molecular pathogenesis.
- Published
- 2018
- Full Text
- View/download PDF
36. [Difficult immunofixation electrophoresis interpretation of serum proteins].
- Author
-
Karfo R, Kabré E, Safir N, Bouabdellah M, Benchekroun L, Sakandé J, and Chabraoui L
- Subjects
- Aged, Female, Humans, Male, Mercaptoethanol chemistry, Middle Aged, Paraproteinemias immunology, Blood Proteins immunology, Immunoelectrophoresis methods, Paraproteinemias diagnosis
- Abstract
Immunofixation is currently very used in medical laboratories. The interpretation of the results is usually easy, but some cases raise interpretative problems. We here report two cases difficult to interpret. In the first case, we report a case of nonspecific precipitation of the protein on each track, in the second case we report a case of double monoclonal band on immunofixation electrophoresis. Reducing agent such as β2-mercaptoethanol used in these two cases allowed to solve the problem and to make a diagnosis. A comparison between clinical radiological and laboratory test data is necessary before making a diagnosis of monoclonal immunoglobulin.
- Published
- 2018
- Full Text
- View/download PDF
37. Heavy+light chain monitoring correlates with clinical outcome in multiple myeloma patients.
- Author
-
Michallet M, Chapuis-Cellier C, Dejoie T, Lombard C, Caillon H, Sobh M, Moreau P, Attal M, and Avet-Loiseau H
- Subjects
- Adult, Aged, Female, Humans, Immunoelectrophoresis methods, Male, Middle Aged, Myeloma Proteins immunology, Prognosis, Progression-Free Survival, Immunoglobulin Heavy Chains immunology, Immunoglobulin Light Chains immunology, Multiple Myeloma immunology
- Abstract
Novel anti-myeloma agents have improved patient response rates, which are historically based on reductions of the M-protein. These methods can be inaccurate for quantifying M-proteins at low concentrations. We compared the consistency and clinical impact of response assignment by electrophoretic and heavy+light chain (HLC) immunoassays post-consolidation in 463 newly diagnosed patients. The two methods gave similar assignments in patients with partial (PR; 79% agreement) or complete response (⩾CR; 92%). However, in patients achieving very good PR (VGPR) there was poor concordance between methods (45%). Median progression-free survival (PFS) for standard VGPR patients was 34.5 months; HLC responses stratified these patients further into PR, VGPR and ⩾CR, with median PFS of 21.3, 28.9 months and not reached, respectively; P<0.001. At this time, abnormal HLC ratios had better concordance with multiparametric flow cytometry (sensitivity 10
-4 ) (37 and 34% positive, respectively), compared to immunofixation (62% positive). In addition, HLC-pair suppression was identified in 38% of patients and associated with shorter PFS (30.6 months vs not reached; P<0.001). We conclude that HLC monitoring could augment electrophoretic assessments in patients achieving VGPR. The prognostic significance of HLC responses might partly depend on the patients' ability to recover their immune system, as determined by normalisation of HLC measurements.- Published
- 2018
- Full Text
- View/download PDF
38. Utility of osteosclerotic lesion biopsy in diagnosis of POEMS syndrome: A case report.
- Author
-
Hara D, Akiyama H, Nukui S, Shimizu T, Hoshikawa M, and Hasegawa Y
- Subjects
- Arthritis, Rheumatoid complications, Arthritis, Rheumatoid drug therapy, Cell Proliferation, Diagnosis, Differential, Female, Humans, Immunoelectrophoresis methods, Immunologic Factors administration & dosage, Lenalidomide, Lupus Erythematosus, Systemic complications, Lupus Erythematosus, Systemic drug therapy, Middle Aged, Neurologic Examination methods, Sjogren's Syndrome complications, Sjogren's Syndrome drug therapy, Thalidomide administration & dosage, Treatment Outcome, Osteosclerosis diagnostic imaging, Osteosclerosis pathology, POEMS Syndrome diagnosis, POEMS Syndrome drug therapy, POEMS Syndrome physiopathology, Plasma Cells immunology, Plasma Cells pathology, Thalidomide analogs & derivatives
- Abstract
Rationale: We report a case of successful diagnosis of POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome based on monoclonality that was confirmed by an osteosclerotic lesion biopsy in a patient without pathognomonic symptoms or monoclonal gammopathy, probably because of comorbidities, which included systemic lupus erythematosus, rheumatoid arthritis, and Sjögren syndrome., Patient Concerns: A 57-year-old woman presented with an approximately 2-year history of numbness in the toes that had gradually spread, along with muscle weakness in both arms and legs. She had been receiving immunosuppressant and corticosteroid therapy since being diagnosed with systemic lupus erythematosus and Sjögren syndrome at the age of 31 years and rheumatoid arthritis at the age of 44 years. Neurological examination revealed predominantly distal hypoesthesia and weakness in a typical stocking-and-glove pattern. Immunoelectrophoresis revealed elevated polyclonal immunoglobulin, which was attributed to her known underlying disease., Diagnoses: Biopsy of an osteosclerotic lesion confirmed proliferation of monoclonal plasma cells, leading to a diagnosis of POEMS syndrome., Interventions and Outcomes: Lenalidomide therapy was started after the diagnosis and the patient had a favorable outcome., Lessons: Osteosclerotic lesion biopsy can be useful for diagnosis of POEMS syndrome in difficult cases.
- Published
- 2017
- Full Text
- View/download PDF
39. Aspergillus antibody detection: diagnostic strategy and technical considerations from the Société Française de Mycologie Médicale (French Society for Medical Mycology) expert committee.
- Author
-
Persat F, Hennequin C, and Gangneux JP
- Subjects
- Enzyme-Linked Immunosorbent Assay methods, Enzyme-Linked Immunosorbent Assay statistics & numerical data, France, Humans, Immunoelectrophoresis methods, Surveys and Questionnaires, Antibodies, Fungal blood, Aspergillosis diagnosis, Aspergillus immunology, Serologic Tests methods
- Abstract
Until now, there has been no consensus on the best method for the detection of anti-Aspergillus antibodies, a key diagnostic tool for chronic aspergilloses. To better appreciate the usage of and confidence in these techniques, the Société Française de Mycologie Médicale (French Society for Medical Mycology; SFMM) performed a two-step survey of French experts. First, we administered an initial survey to French labs performing Aspergillus serology to depict usage of the different techniques available for Aspergillus serology. Second, an opinion poll was conducted of 40 experts via an online questionnaire. Each item was rated from 1 to 9 according to the level of agreement. The initial survey revealed that enzyme-linked immunosorbent assay (ELISA) (81%) and immunoelectrophoresis (IEP) (67%) were the most commonly used techniques for screening and confirmation, respectively. The distinction between screening and confirmation techniques was confirmed by the experts (median = 7) with a 44.2% variation coefficient. Only ELISA for screening and IEP and Western blot (WB) for confirmation were clearly considered valuable methods (median ≥8 with variation coefficients less than 30%). The use of a confirmation technique was recommended in the case of a positive result in a compatible clinical context (cystic fibrosis, for example) or during the patient's follow-up. In the case of discordant results between the screening and confirmation techniques, the experts recommended greater confidence in the results obtained with the confirmation technique. All experts emphasized the need to standardize Aspergillus serology techniques and to better define the place of each of them in the diagnosis of aspergillosis., (© The Author 2016. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2017
- Full Text
- View/download PDF
40. Comparison of Fully Automated and Semiautomated Systems for Protein Immunofixation Electrophoresis.
- Author
-
Napodano C, Pocino K, Gulli F, Colacicco L, Santini SA, Zuppi C, and Basile U
- Subjects
- Automation, Laboratory instrumentation, Automation, Laboratory methods, Blood Proteins analysis, Female, Humans, Immunoelectrophoresis instrumentation, Immunoelectrophoresis methods, Male, Blood Protein Electrophoresis instrumentation, Blood Protein Electrophoresis methods, Immunoglobulin Heavy Chains blood, Immunoglobulin Heavy Chains urine, Immunoglobulin Light Chains blood, Immunoglobulin Light Chains urine, Paraproteinemias diagnosis
- Abstract
Background: In order to establish a diagnosis of monoclonal gammopathy, it is necessary to detect and identify monoclonal components. To confirm the immunological nature of the proteins, the next step is to define their composition in heavy and light chains using immunofixation. The purpose of this study was to compare two different instruments, one semiautomated and the other fully automated for serum and urine immunofixation., Methods: We selected 150 sera and 100 urines from patients admitted for routine analysis, which were analyzed by immunofixation to characterize monoclonal components., Results and Conclusion: Comparison study showed a difference in the identification of small monoclonal components and hypogammaglobulinemia, in serum and urine, between the two analyzers. We also observed a difference in the length of the electrophoretic pattern that is of considerable importance as it leads to a better resolution of the gamma region, allowing to identify even the smallest monoclonal component that can be easily hide in an oligoclonal pattern. For this reason, there is need to ameliorate commercial immunofixation assays. It is essential to improve data harmonization and standardize measurement procedures in order to guarantee a correct diagnosis for the right patient care., (© 2016 Wiley Periodicals, Inc.)
- Published
- 2017
- Full Text
- View/download PDF
41. Interference by biological anti-cancer drugs in electrophoretic and immunofixation techniques.
- Author
-
Cigliana G, Illuminati G, De Santis E, Conti L, Pisani F, La Malfa A, Longhi E, Gottardi O, D'Ambrosio M, Gelsumini S, and Vernocchi A
- Subjects
- Humans, Antineoplastic Agents metabolism, Blood Protein Electrophoresis methods, Blood Proteins metabolism, Electrophoresis, Agar Gel methods, Electrophoresis, Capillary methods, Immunoelectrophoresis methods
- Published
- 2016
- Full Text
- View/download PDF
42. Serial multiple crossed immunoelectrophoresis at a microscale: A stamp-sized 2D immunoanalysis of protein C3 activation caused by nanoparticles.
- Author
-
Coty JB, Varenne F, Vachon JJ, and Vauthier C
- Subjects
- Analysis of Variance, Reproducibility of Results, Complement C3 analysis, Immunoelectrophoresis methods
- Abstract
Crossed immunoelectrophoresis (C-IE) is used to detect and quantify specific proteins. An application allowed the evaluation of complement system activation by nanomaterials. The work aimed to improve the C-IE toward a higher throughput and less tedious method. A new concept was implemented to prepare and run agarose gels. The first and the second dimension of electrophoresis were performed on a single gel plate, prepared before the beginning of the analysis. Several samples were migrated simultaneously on the same migration line. Up to 35 analyses were run at once, providing stamp-sized electrophoregrams (2.8 × 3 cm(2) ) maintaining the performance of the original method performed on 5 × 7 cm(2) gel slabs. Robustness and precision of the method were demonstrated through a validation approach using ANOVA. Handling, experimental duration, amount of reagents, and overall cost of one analysis were considerably reduced compared to the original method. With the same equipment, seven times more analyses can be performed in one run. C-IE can be used to analyze many types of proteins. The new experimental modalities were suitable for the application developed in the present work that was to evaluate activation of protein C3 of the complement system triggered by nanomaterials., (© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.)
- Published
- 2016
- Full Text
- View/download PDF
43. Should routine laboratories stop doing screening serum protein electrophoresis and replace it with screening immune-fixation electrophoresis? No quick fixes: Counterpoint.
- Author
-
Smith JD, Raines G, and Schneider HG
- Subjects
- Humans, Immunoglobulin Light Chains blood, Immunoglobulin Light Chains urine, Limit of Detection, Paraproteinemias blood, Paraproteinemias urine, Blood Protein Electrophoresis methods, Immunoelectrophoresis methods, Paraproteinemias diagnosis
- Abstract
Monoclonal gammopathies are characterised by the production of a monoclonal immunoglobulin or free light chains by an abnormal plasma cell or B-cell clone and may indicate malignancy or a precursor (MGUS). There is currently no consensus on the initial test or combination of tests to be performed in suspected monoclonal gammopathies but serum protein electrophoresis and urine protein electrophoresis are commonly requested as initial investigations. If abnormal, immunofixation electrophoresis is then performed to confirm the presence of paraprotein and to determine its heavy and light chain type. Recently, some groups have developed simplified "screening" IFE methods for use in parallel to SPEP for the detection monoclonal gammopathies. We argue here that screening IFE may be of benefit in clinical laboratories using SPEP with poor resolution in the β-region, assisting in the detection of mainly IgA paraprotein, but may be of less benefit in laboratories utilising higher resolution gels. Further it may increase the detection of trace bands of questionable clinical significance, representing transient phenomena in infectious and auto-immune conditions or very low risk MGUS. The increased detection of these bands using screening IFE would require further patient follow up, possibly causing unnecessary patient anxiety and additional follow up healthcare costs.
- Published
- 2016
- Full Text
- View/download PDF
44. Screening immunofixation should replace protein electrophoresis as the initial investigation of monoclonal gammopathy: Point.
- Author
-
Pretorius CJ
- Subjects
- Humans, Immunoglobulin Light Chains blood, Immunoglobulin Light Chains urine, Limit of Detection, Multiple Myeloma diagnosis, Multiple Myeloma immunology, Paraproteinemias blood, Paraproteinemias urine, Paraproteins urine, Blood Protein Electrophoresis methods, Immunoelectrophoresis methods, Paraproteinemias diagnosis
- Abstract
The reliable detection of paraprotein in serum and urine is the primary purpose of electrophoretic procedures in clinical laboratories. Screening immunofixation electrophoresis (sIFE) employs a single application of antisera directed against heavy and light chains that facilitates the detection of paraproteins that migrate in the non-γ region or that are below the detection limit of protein electrophoresis. These paraproteins that are missed by routine electrophoresis occur in up to 27.3% of newly investigated and 13.6% of monitored patients. Small paraproteins missed by conventional electrophoretic techniques are clinically important in the diagnosis and monitoring of malignant plasma and B-cell disorders. The superior diagnostic performance of sIFE makes it suitable as the initial laboratory procedure to investigate paraproteins in complex serum and urine matrices.
- Published
- 2016
- Full Text
- View/download PDF
45. Antioxidant and immunomodulatory properties of polysaccharides from Allanblackia floribunda Oliv stem bark and Chromolaena odorata (L.) King and H.E. Robins leaves.
- Author
-
Boudjeko T, Megnekou R, Woguia AL, Kegne FM, Ngomoyogoli JE, Tchapoum CD, and Koum O
- Subjects
- Antioxidants analysis, Antioxidants isolation & purification, Benzothiazoles chemistry, Biphenyl Compounds chemistry, Cell Proliferation drug effects, Cells, Cultured, Chromatography, Gas, Enzyme-Linked Immunospot Assay, Free Radical Scavengers analysis, Free Radical Scavengers isolation & purification, Free Radical Scavengers pharmacology, Humans, Immunoelectrophoresis methods, Immunologic Factors analysis, Immunologic Factors isolation & purification, Interferon-gamma biosynthesis, Iron Chelating Agents analysis, Iron Chelating Agents isolation & purification, Iron Chelating Agents pharmacology, Leukocytes, Mononuclear cytology, Leukocytes, Mononuclear drug effects, Leukocytes, Mononuclear metabolism, Monosaccharides analysis, Monosaccharides isolation & purification, Oxidation-Reduction drug effects, Phenols analysis, Phenols isolation & purification, Picrates chemistry, Plant Extracts analysis, Plant Extracts isolation & purification, Plant Extracts pharmacology, Plant Proteins analysis, Plant Proteins isolation & purification, Polysaccharides analysis, Polysaccharides isolation & purification, Sulfonic Acids chemistry, Antioxidants pharmacology, Chromolaena chemistry, Clusiaceae chemistry, Immunologic Factors pharmacology, Plant Leaves chemistry, Polysaccharides pharmacology
- Abstract
Background: Many plant polysaccharides have shown high antioxidant and immunostimulating properties and can be explored as novel molecules with biological properties that can potentially improve immune function. The objective of this work was to characterize soluble and cell wall polysaccharides isolated from the stem bark of Allanblackia floribunda and Chromolaena odorata leaves and to evaluate their antioxidant and immunomodulatory properties., Methods: Three polysaccharide fractions: soluble polysaccharides (PoS), pectins (Pec) and hemicelluloses (Hem) were extracted from A. floribunda stem bark and C. odorata leaves. These samples were analysed for their proteins, phenolic compounds and total sugar contents. The monosaccharide composition was determined by gas chromatography and arabinogalactan proteins content in PoS was evaluated by rocket electrophoresis. The in vitro antioxidant activities were evaluated by 1, 1-diphenyl-2-picryl hydrazyl (DPPH) and 2,2'-azino-bis-3-éthylbenzylthiazoline-6-sulphonic acid (ABTS) radical scavenging assays and ferrous ions chelating activity. Immunomodulatory activities were performed on the peripheral blood mononuclear cells (PBMCs) using proliferation and enzyme linked immunospot (ELISPOT) method to determine the production of an interferon-gamma., Results: The characterization of the various fractions showed varied metabolites in each plant. In PoS fractions, Ara and Gal were the major monosaccharides found, indicating that arabinogalactans are the primary macromolecules. Hem fractions contained predominantly Xyl and GalA for A. floribunda and Xyl (upto 80 %) for and C. odorata. A. floribunda Hem fraction and C. odorata PoS fraction showed significant DPPH and ABTS radical scavenging activities and immunostimulatory activity via stimulation of PBMC and production of IFN-γ in a dose-dependent manner., Conclusion: The results obtained from this study support the ethnomedicinal use of the stem bark of A. floribunda and leaves of C. odorata. Further research is necessary to have supporting evidence that the antioxidative and immunomodulative activities of these fractions are really connected to the polysaccharides and not polyphenols.
- Published
- 2015
- Full Text
- View/download PDF
46. Application of capillary immunoelectrophoresis revealed an age- and gender-dependent regulated expression of PrPC in liver.
- Author
-
Arora AS, Zafar S, Kollmar O, Llorens F, Tahir W, Vanselow S, Kumar P, Schmerr MJ, Schmitz M, and Zerr I
- Subjects
- Animals, Blotting, Western, Female, Humans, Liver metabolism, Male, Mice, Mice, Inbred C57BL, PrPC Proteins genetics, PrPC Proteins metabolism, Sex Factors, Aging physiology, Electrophoresis, Capillary methods, Immunoelectrophoresis methods
- Abstract
The cellular prion protein (PrPC) is a glycoprotein, anchored to the plasma membrane and abundantly expressed in the central nervous system. The expression of PrPC in the peripheral tissues is low and only little information is available on its functions in the nonneuronal tissues. The antioxidant function of PrPC during the activation of hepatic stellate cells has already been reported. Therefore, the aim of the study was to expand our knowledge on the functions of PrPC by detailed characterization of its expressional profile in the liver. In a combined strategy by using capillary immunoelectrophoresis and standard techniques, we have shown a sexually dimorphic expression of PrPC in mice and human liver tissues. Further, we showed a significant age-dependent upregulation of PrPC expression in the liver of 14- and 9-month-old mice as compared to 3 months of age. Therefore, this study may provide new insights into the gender-specific role of PrPC in the liver, which may further be linked to its protective role against oxidative stress during aging. In addition, the current study also shows an application of immunoelectrophoresis with a low coefficient of variation to analyze the miniscule amount of PrPC in the mouse liver tissue., (© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.)
- Published
- 2015
- Full Text
- View/download PDF
47. Monitoring IgA multiple myeloma: immunoglobulin heavy/light chain assays.
- Author
-
Katzmann JA, Willrich MA, Kohlhagen MC, Kyle RA, Murray DL, Snyder MR, Rajkumar SV, and Dispenzieri A
- Subjects
- Blood Protein Electrophoresis methods, Humans, Immunoelectrophoresis methods, Immunoglobulin G blood, Immunoglobulin M blood, Immunoassay methods, Immunoglobulin A blood, Immunoglobulin Heavy Chains blood, Immunoglobulin Light Chains blood, Multiple Myeloma blood
- Abstract
Background: The use of electrophoresis to monitor monoclonal immunoglobulins migrating in the β fraction may be difficult because of their comigration with transferrin and complement proteins., Methods: Immunoassays specific for IgGκ, IgGλ, IgAκ, IgAλ, IgMκ, and IgMλ heavy/light chain (HLC) were validated for use in the clinical laboratory. We assessed sample stability, inter- and intraassay variability, linearity, accuracy, and reference intervals for all 6 assays. We tested accuracy by verifying that the sum of the concentrations for the HLC-pairs accounted for the total immunoglobulins in each of 129 healthy sera, and that the HLC-pair ratios (rHLCs) were outside the reference interval in 97% of 518 diagnostic multiple myeloma (MM) samples., Results: We assessed diagnostic samples and posttreatment sera in 32 IgG and 30 IgA patients for HLC concentrations, rHLC, and total immunoglobulins and compared these nephelometry results with serum protein electrophoresis (SPEP) and immunofixation electrophoresis (IFE). In sample sets from patients with IgG MM, the sensitivity of SPEP was almost the same as for rHLC, and no additional advantage was conferred by running HLC assays. In pre- and posttreatment samples from patients with IgA MM, the SPEP, rHLC, and IFE identified clonality in 28%, 56%, and 61%, respectively. In addition, when M-spikes were quantifiable, the concentration of the involved HLC was linearly related to that of the SPEP M-spike, with a slope near 1., Conclusions: The use of IgA HLC assays for monitoring β-migrating IgA monoclonal proteins can substitute for the combination of SPEP, IFE, and total IgA quantification., (© 2014 American Association for Clinical Chemistry.)
- Published
- 2015
- Full Text
- View/download PDF
48. Validation of a lipoprotein(a) particle concentration assay by quantitative lipoprotein immunofixation electrophoresis.
- Author
-
Guadagno PA, Summers Bellin EG, Harris WS, Dayspring TD, Hoefner DM, Thiselton DL, Stanovick B, Warnick GR, and McConnell JP
- Subjects
- Humans, Immunoelectrophoresis methods, Immunoelectrophoresis standards, Lipoprotein(a) blood
- Abstract
Background: Low-density lipoprotein (LDL) particle (P, or molar) concentration has been shown to be a more sensitive marker of cardiovascular disease (CVD) risk than LDL cholesterol. Although elevated circulating lipoprotein(a) [Lp(a)] cholesterol and mass have been associated with CV risk, no practicable method exists to measure Lp(a)-P. We have developed a method of determining Lp(a)-P suitable for routine clinical use., Methods: Lipoprotein immunofixation electrophoresis (Lipo-IFE) involves rigidly controlled electrophoretic separation of serum lipoproteins, probing with polyclonal apolipoprotein B antibodies, then visualization after staining with a nonspecific protein stain (Acid Violet). Lipo-IFE was compared to the Lp(a) mass assay for 1086 randomly selected patient samples, and for 254 samples stratified by apo(a) isoform size., Results: The Lipo-IFE method was shown to be precise (CV <10% above the 50 nmol/l limit of quantitation) and linear across a 16-fold range. Lipo-IFE compared well with the mass-based Lp(a) assay (r=0.95), but was not affected by variations in apo(a) isoform size. With a throughput of 100 samples in 90 min, the assay is suitable for use in the clinical laboratory., Conclusions: The Lipo-IFE method will allow Lp(a)-P to be readily tested as a CVD risk factor in large-scale clinical trials., (Copyright © 2014. Published by Elsevier B.V.)
- Published
- 2015
- Full Text
- View/download PDF
49. Diagnosing Aleutian mink disease infection by a new fully automated ELISA or by counter current immunoelectrophoresis: a comparison of sensitivity and specificity.
- Author
-
Dam-Tuxen R, Dahl J, Jensen TH, Dam-Tuxen T, Struve T, and Bruun L
- Subjects
- Aleutian Mink Disease Virus immunology, Animals, Denmark, Enzyme-Linked Immunosorbent Assay methods, Immunoelectrophoresis methods, Mink, Sensitivity and Specificity, Aleutian Mink Disease diagnosis, Aleutian Mink Disease Virus isolation & purification, Clinical Laboratory Techniques methods, Diagnostic Tests, Routine methods
- Abstract
Aleutian disease (AD) is a severe disease characterized by hypergammaglobulinemia causing multiple symptoms such as acute renal failure, arteritis, reduced reproductive performance and pneumonia in mink. AD is caused by the parvovirus Aleutian mink disease virus (ADV) and diagnosed primarily based on ADV serology sometimes supplemented by organ PCR analysis. In Denmark, approximately 3.5-4 million serum samples are tested every year for the presence of anti ADV antibodies as part of a national eradication program. The present study compares the diagnostic performance of the two most commonly used assays for serological screening for Aleutian disease: counter current immunoelectrophoresis (CIEP) and ELISA. In total, 3810 mink were sampled in doublets and analyzed by CIEP and a newly developed fully automated ELISA. The results show that the two assays have a comparable diagnostic performance with the ELISA having a higher sensitivity but lower specificity than the CIEP assay. The ELISA has been approved by the Danish authorities for diagnosing Aleutian disease in mink., (Copyright © 2014 Elsevier B.V. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
50. Identification of the antigen content of electroimmunoprecipitates.
- Author
-
Beyer NH and Heegaard NH
- Subjects
- Animals, Humans, Antigens analysis, Immunoelectrophoresis methods, Immunoprecipitation methods
- Abstract
Polyclonal antibodies including purified antibody fractions and animal or human antisera may react with unknown antigens or antigens other than their main specificity in reactions that are best visualized by gel electroimmunoprecipitation methods, e.g., when analyzing complex antigen mixtures. The great advantage of gel immunoprecipitation approaches is that each immunoprecipitate contains antigen in a pure form and that the precipitate is separated by position, shape, and size from other precipitates in the complex patterns of crossed immunoelectrophoresis. The identification of the antigen content of such immunoprecipitates is important but challenging because of the very stable, high affinity complex formation leading to precipitation in the gels. Here, we present detailed step-by-step recipes for identifying the antigen content of electroimmunoprecipitates.
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.